Retinal dysfunction and anterior segment deposits in a patients treated with rifabutin

Acta Ophthalmologica Scandinavica

Volumn 80, Issue 5, 2002, Pages 553-556

  Ponjavic, V ^a   Granse L ^a   Bengtsson Stigmar, E ^a   Andreasson S ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Drug side effect; Full field electroretinography; Multifocal electroretinography; Retinal dysfunction; Rifabutin

Indexed keywords

RIFABUTIN;

ANTERIOR EYE SEGMENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA DISEASE; DRUG ACCUMULATION; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; EYE FUNDUS; EYE PHOTOGRAPHY; HUMAN; LENS DISEASE; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; OPHTHALMOSCOPY; OSTEOMYELITIS; PERIMETRY; PRIORITY JOURNAL; RETINA DISEASE; SCHOOL CHILD; SLIT LAMP; VISUAL ACUITY; VISUAL FIELD; VISUAL SYSTEM EXAMINATION;

ANTERIOR EYE SEGMENT; ANTIBIOTICS, ANTITUBERCULAR; CHILD; ELECTRORETINOGRAPHY; HUMANS; MALE; OSTEOMYELITIS; RETINA; RETINAL DISEASES; RIFABUTIN; VISUAL ACUITY; VISUAL FIELDS;

EID: 0036772692     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800519.x     Document Type: Article

References (22)

1. Andréasson S & Ponjavic V (1997): Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene. Am J Ophthalmol 124: 95-102.
2. Arevalo JF et al. (1997): New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthalmic Surg Lasers 28: 321-324.
3. Bearse MA & Sutter EE (1996): Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A 13: 634-640.
4. Becker K et al. (1996): Anterior uveitis associated with rifabutin medication in AIDS patients. Infection 24: 34-36.
5. Brogden RN & Fitton A (1994): Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 983-1009.
6. Brughera M et al. (1995): Overview of toxicological data on rifabutin. Exp Toxic Pathol 47: 1-9.
7. Chaknis MJ et al. (1996): Inflammatory opacities of the vitreous in rifabutin-associated uveitis. Am J Ophthalmol 122: 580-582.
8. Chu DS et al. (2001): Human immunodeficiency virus-positive patients with posterior intracorneal precipitates. Ophthalmology 108: 1853-1857.
9. Fineman MS et al. (2001): Hypopion uveitis in immunocompetent patients treated for Mycobacterium avium complex pulmonary infection with rifabutin. Retina 21: 531-533.
10. Fraunfelder FT & Meyer SM (1989): Drug-Induced Ocular Side Effects and their Drug Interactions. Third edn. Philadelphia: Lea and Febiger.
11. Fraunfelder FW & Rosembaum JT (1997): Drug-induced uveitis. Incidence, prevention and treatment. Drug Safety 17: 197-207.
12. Grant WM (1986): Toxicology of the Eye. Third edn. Springfield, Illinois: Charles C Thomas.
13. Holland SP et al. (1999): Corneal endothelial deposits in patients with HIV infection or AIDS: epidemiologic evidence of the contribution of rifabutin. Can J Ophthalmol 34: 204-209.
14. Imperia PS et al. (1989): Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 34: 209.
15. Jacobs DS et al. (1994): Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol 118: 716-722.
16. Novack GD (1997): Ocular toxicology. Current Opinion. Ophthalmol 8: 88-92.
17. Pavan-Langston D & Dunkel EC (1991): Handbook of Ocular Drug Therapy and Ocular Side Effects of the Systemic Drugs. Boston: Little, Brown.
18. Rennie IG (1993): Clinically important ocular reactions to systemic drug therapy. Drug Safety 9: 196-211.
19. Saran BR et al. (1994): Hypopion uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 112: 1159-1165.
20. Smith JA et al. (1999): Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia. Am J Ophthalmol 127: 164-169.
21. Soukasian SK & Raizman MB (2000): Ocular toxicity of systemic medications. In: Albert DM, Jacobiec FA (eds). Principles and Practise of Ophthalmology. Philadelphia: WB Saunders Company. 455-468.
22. Sutter EE & Tran D (1992): The field topography of ERG components in man. I: The photopic luminance response. Vision Res 32: 433-446.